Skip to content

Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis.

Meta-analysis · Curr Alzheimer Res · 2022. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 35048806

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Comparative Efficacy and Acceptability of Cholinesterase Inhibitors and Memantine Based on Dosage in Patients with Vascular Cognitive Impairment: A Network Meta-analysis.

Shi X, Ren G, Cui Y et al.
Curr Alzheimer Res · 2022

PubMed ID
35048806
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.